Haichuang Pharmaceutical (688302.SH) released its 2023 annual results forecast and is expected to return to 2023...
According to the Zhitong Finance App, Haichuang Pharmaceutical (688302.SH) released its 2023 annual results forecast. It is expected to achieve net profit attributable to owners of the parent company in 2023 of -326 million yuan to -272 million yuan, or -30,1514,800 yuan for the same period last year. It is expected to achieve net profit of 363 million yuan to -303 million yuan after deducting non-recurring profit and loss attributable to the owners of the parent company in 2023, compared to -34,05219 million yuan for the same period last year.
